Ace Inhibitors, Angiotensin Receptor Blockers, and Outcomes in Hospitalized Patients With Severe Covid-19 Pneumonia

被引：0
|
作者：
Grewal, Prabhjot
Yoo, Jeanwoo
Papamanoli, Aikaterini
Mojahedi, Azad
Dhaliwal, Simrat
Nakamura, Jacquelyn
Abata, Joshua
Robin, Jacob
Fung, Jenny
Hotelling, Jessica
Rawal, Sahil
Karkala, Nikitha
Tsui, Stella T.
Coritsidis, Alexandra
Marcos, Luis
Bloom, Michelle E.
Skopicki, Hal
Kalogeropoulos, Andreas P.
机构：
来源：
CIRCULATION | 2020年 / 142卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A15514
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Assessment of ACE inhibitors/angiotensin receptor blockers in COVID-19 patients
    Sriram, Krishna
    Insel, Paul A.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2020, 319 (01) : L37 - L38
  • [2] Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID-19
    Pan, Michael
    Vasbinder, Alexi
    Anderson, Elizabeth
    Catalan, Toniemarie
    Shadid, Husam R.
    Berlin, Hanna
    Padalia, Kishan
    O'Hayer, Patrick
    Meloche, Chelsea
    Azam, Tariq U.
    Khaleel, Ibrahim
    Michaud, Erinleigh
    Blakely, Pennelope
    Bitar, Abbas
    Huang, Yiyuan
    Zhao, Lili
    Pop-Busui, Rodica
    Loosen, Sven H.
    Chalkias, Athanasios
    Tacke, Frank
    Giamarellos-Bourboulis, Evangelos J.
    Reiser, Jochen
    Eugen-Olsen, Jesper
    Hayek, Salim S.
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (24):
  • [3] ACE inhibitors, angiotensin receptor blockers and endothelial injury in COVID-19
    Tetlow, S.
    Segiet-Swiecicka, A.
    O'Sullivan, R.
    O'Halloran, S.
    Kalb, K.
    Brathwaite-Shirley, C.
    Alger, L.
    Ankuli, A.
    Baig, M. S.
    Catmur, F.
    Chan, T.
    Dudley, D.
    Fisher, J.
    Iqbal, M. U.
    Puczynska, J.
    Wilkins, R.
    Bygate, R.
    Roberts, P.
    [J]. JOURNAL OF INTERNAL MEDICINE, 2021, 289 (05) : 688 - 699
  • [4] Effect of ACE inhibitors and angiotensin receptor blockers on in-hospital mortality and length of stay in hospitalized COVID-19 patients
    LaClair, Heather J.
    Khosrodad, Nadia
    Sule, Anupam A.
    Koehler, Tracy
    Krishnamoorthy, Geetha
    [J]. VASCULAR PHARMACOLOGY, 2021, 141
  • [5] In-hospital use of ACE inhibitors/angiotensin receptor blockers associates with COVID-19 outcomes in African American patients
    Li, Shilong
    Sarangarajan, Rangaprasad
    Jun, Tomi
    Kao, Yu-Han
    Wang, Zichen
    Hao, Ke
    Schadt, Emilio
    Kiebish, Michael A.
    Granger, Elder
    Narain, Niven R.
    Chen, Rong
    Schadt, Eric E.
    Li, Li
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2021, 131 (19):
  • [6] Assessing the outcomes of prescribing angiotensin converting enzyme inhibitors and angiotensin receptor blockers for COVID-19 patients
    Mekary, Wissam
    Fares, Souha
    Abdulhai, Farah
    Massoud, Gaelle
    Refaat, Marwan
    Mericskay, Mathias
    Booz, George W.
    Zouein, Fouad A.
    [J]. HELIYON, 2023, 9 (09)
  • [7] The effect of ACE inhibitors and ARBs on outcomes in hospitalized patients with COVID-19
    Najafi, Narges
    Davoudi, Alireza
    Izadyar, Hamideh
    Alishahi, Abbas
    Mokhtariani, Armaghan
    Soleimanpourian, Bahareh
    Tabarrayi, Mina
    Moosazadeh, Mahmood
    Daftarian, Zahra
    Ahangarkani, Fatemeh
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2023, 192 (03) : 1517 - 1523
  • [8] The effect of ACE inhibitors and ARBs on outcomes in hospitalized patients with COVID-19
    Narges Najafi
    Alireza Davoudi
    Hamideh Izadyar
    Abbas Alishahi
    Armaghan Mokhtariani
    Bahareh Soleimanpourian
    Mina Tabarrayi
    Mahmood Moosazadeh
    Zahra Daftarian
    Fatemeh Ahangarkani
    [J]. Irish Journal of Medical Science (1971 -), 2023, 192 (3): : 1517 - 1523
  • [9] Angiotensin converting enzyme inhibitors and angiotensin receptor blockers improved the outcome of patients with severe COVID-19 and hypertension
    Xiao Meng
    Ya Liu
    Chenchen Wei
    Kai Zhang
    Yi Zhang
    Ming Zhong
    Cheng Zhang
    Yun Zhang
    [J]. Science China Life Sciences, 2021, 64 (05) : 836 - 839
  • [10] Angiotensin converting enzyme inhibitors and angiotensin receptor blockers improved the outcome of patients with severe COVID-19 and hypertension
    Meng, Xiao
    Liu, Ya
    Wei, Chenchen
    Zhang, Kai
    Zhang, Yi
    Zhong, Ming
    Zhang, Cheng
    Zhang, Yun
    [J]. SCIENCE CHINA-LIFE SCIENCES, 2021, 64 (05) : 836 - 839
12345